SAKAR HEALTHCARE
Back to Income Statement
|
SAKAR HEALTHCARE Last 5 Year Revenue History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Sales | ₹252 Cr | ₹178 Cr | ₹153 Cr | ₹133 Cr | ₹128 Cr |
What is the latest Revenue of SAKAR HEALTHCARE ?
| Year | Revenue |
|---|---|
| Mar2026 | ₹252 Cr |
| Mar2025 | ₹178 Cr |
| Mar2024 | ₹153 Cr |
| Mar2023 | ₹133 Cr |
| Mar2022 | ₹128 Cr |
How is Revenue of SAKAR HEALTHCARE Trending?
| Years | Revenue | % Change | |
|---|---|---|---|
| Mar2026 | ₹252 Cr | 41.76 | |
| Mar2025 | ₹178 Cr | 15.80 | |
| Mar2024 | ₹153 Cr | 14.99 | |
| Mar2023 | ₹133 Cr | 4.00 | |
| Mar2022 | ₹128 Cr | - | |
Compare Revenue of peers of SAKAR HEALTHCARE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SAKAR HEALTHCARE | ₹2,195.6 Cr | 3.9% | -12.9% | 155% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹421,803.0 Cr | 0.2% | -5.2% | 4.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹253,833.0 Cr | 4.9% | -0.5% | 43.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹173,461.0 Cr | -1.1% | -8.5% | 28.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,463.0 Cr | 7.8% | 11% | 1.2% | Stock Analytics | |
| CIPLA | ₹109,870.0 Cr | 2.3% | -2.7% | -18.9% | Stock Analytics | |
SAKAR HEALTHCARE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SAKAR HEALTHCARE | 3.9% |
-12.9% |
155% |
| SENSEX | -0.6% |
-0.5% |
-13.2% |
You may also like the below Video Courses